Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Preformed Line Products (PLPC) Cash & Equivalents (2016 - 2025)

Preformed Line Products (PLPC) has disclosed Cash & Equivalents for 5 consecutive years, with $28.7 million as the latest value for Q3 2014.

  • On a quarterly basis, Cash & Equivalents fell 7.8% to $28.7 million in Q3 2014 year-over-year; TTM through Sep 2014 was $28.7 million, a 7.8% decrease, with the full-year FY2013 number at $24.3 million, down 13.62% from a year prior.
  • Cash & Equivalents was $28.7 million for Q3 2014 at Preformed Line Products, up from $24.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $32.1 million in Q4 2011 to a low of $21.2 million in Q1 2014.
  • A 5-year average of $26.4 million and a median of $25.8 million in 2013 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 41.81% in 2011, then decreased 21.65% in 2014.
  • Preformed Line Products' Cash & Equivalents stood at $22.7 million in 2010, then surged by 41.81% to $32.1 million in 2011, then dropped by 12.47% to $28.1 million in 2012, then decreased by 13.62% to $24.3 million in 2013, then increased by 18.24% to $28.7 million in 2014.
  • Per Business Quant, the three most recent readings for PLPC's Cash & Equivalents are $28.7 million (Q3 2014), $24.6 million (Q2 2014), and $21.2 million (Q1 2014).